中华中医药学刊2024,Vol.42Issue(9) :115-119,后插14.DOI:10.13193/j.issn.1673-7717.2024.09.023

墨旱莲及蟛蜞菊内酯抗骨质疏松研究进展

Research Progress of Mohanlian(Ecliptae Herba)and Wedelolactone in Anti-Osteoporosis

马毓 赵翔凤 杨素文 魏君 刘艳秋
中华中医药学刊2024,Vol.42Issue(9) :115-119,后插14.DOI:10.13193/j.issn.1673-7717.2024.09.023

墨旱莲及蟛蜞菊内酯抗骨质疏松研究进展

Research Progress of Mohanlian(Ecliptae Herba)and Wedelolactone in Anti-Osteoporosis

马毓 1赵翔凤 1杨素文 1魏君 1刘艳秋1
扫码查看

作者信息

  • 1. 山东中医药大学中医学院,山东济南 250355
  • 折叠

摘要

骨质疏松症(osteoporosis,OP)是一种常见的骨代谢疾病,以骨量减少、骨微观结构改变、易发生骨折为特征的骨质病变.目前,西药治疗OP往往会引起不同程度的不良反应,中药治疗OP具有一定优势和特色.以中医理论"肾主骨生髓"为指导,补肾中药常用于临床治疗OP,效果显著.墨旱莲(Ecliptae Herba)为滋补肝肾的传统中药.新近研究表明,墨旱莲及其主要成分蟛蜞菊内酯具有良好的抗骨质疏松作用.对墨旱莲及蟛蜞菊内酯防治OP的骨形成、骨吸收作用及潜在分子机制进行综述,旨在为墨旱莲及蟛蜞菊内酯的临床应用与开发提供借鉴.

Abstract

Osteoporosis(OP)is a common bone metabolic disease characterized by reduced bone mass,changes in bone mi-crostructure and susceptibility to fractures.At present,western medicine treatment often causes different degrees of adverse reac-tions.Traditional Chinese medicine has certain advantages and characteristics in the treatment of OP.Guided by the theory of traditional Chinese medicine"kidney governing bone marrow",kidney-tonifying Chinese drugs are often used in clinical treat-ment of OP,and the effect is significant.Mohanlian(Ecliptae Herba)is a traditional Chinese drug for nourishing liver and kid-ney.Recent studies shows that Mohanlian(Ecliptae Herba)and its main component wedelolactone has good anti-osteoporosis effects.In this paper,the bone formation,bone resorption effects and potential molecular mechanisms of Mohanlian(Ecliptae Her-ba)and wedelolactone in the prevention and treatment of OP were reviewed,aiming to provide a reference for the clinical applica-tion and development of Mohanlian(Ecliptae Herba)and wedelolactone.

关键词

墨旱莲/蟛蜞菊内酯/骨质疏松/分子机制/信号通路

Key words

Mohanlian(Ecliptae Herba)/wedelolactone/osteoporosis/molecular mechanism/signal pathway

引用本文复制引用

出版年

2024
中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
段落导航相关论文